This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
100mg | $1150 | Check With Us |
250mg | $2050 | Check With Us |
500mg | $3075 | Check With Us |
Cat #: V30970 CAS #: 309913-83-5 Purity ≥ 99%
Description: Talmapimod, formerly known as SCIO-469, is a novel, orally bioavailable, and selective p38 mitogen-activated protein kinase (MAPK) inhibitor (IC50 = 9 nM) with potential immunomodulating, anti-inflammatory, and antineoplastic activities.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 513.00 |
---|---|
Molecular Formula | C27H30ClFN4O3 |
CAS No. | 309913-83-5 |
SMILES Code | O=C(N(C)C)C(C1=CN(C)C2=C1C=C(C(N3[C@H](C)CN(CC4=CC=C(F)C=C4)[C@@H](C)C3)=O)C(Cl)=C2)=O |
Synonyms | SD282, SD-282, SD 282, SCIO282, SCI O282, SCI-O282, Talmapimod |
Protocol | In Vitro | Talmapimod (SCIO-469) (100-200 nM; 1 hour) inhibits phosphorylation of p38 MAPK in MM cells. |
---|---|---|
In Vivo | Targeting p38α MAPK with Talmapimod (SCIO-469) decreases myeloma burden in addition to preventing the development of myeloma bone disease. |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.9493 mL | 9.7466 mL | 19.4932 mL | 38.9864 mL |
5mM | 0.3899 mL | 1.9493 mL | 3.8986 mL | 7.7973 mL |
10mM | 0.1949 mL | 0.9747 mL | 1.9493 mL | 3.8986 mL |
20mM | 0.0975 mL | 0.4873 mL | 0.9747 mL | 1.9493 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.